Lv12
50 积分 2023-06-04 加入
Mepolizumab in severe uncontrolled CRSwNP: a real-life multicentre study in Northeast Italy
19天前
已完结
Next-Generation Anti-IL-17 Agents for Psoriatic Disease: A Pipeline Review
20天前
已完结
Long-term efficacy and safety of secukinumab in patients with psoriatic arthritis: 5-year (end-of-study) results from the phase 3 FUTURE 2 study
21天前
已完结
Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
21天前
已完结
Long-term efficacy and safety of secukinumab in patients with psoriatic arthritis: 5-year (end-of-study) results from the phase 3 FUTURE 2 study
21天前
已完结
银屑病关节炎近十年研究热点
25天前
已完结
银屑病关节炎诊疗规范
27天前
已完结
银屑病关节炎早期识别与诊治专家共识（2025版）
28天前
已完结
Complement inhibitors in pediatric kidney diseases: new therapeutic opportunities
1个月前
已完结
Expert Recommendations on Use of Topical Therapeutics for Vitiligo in Pediatric, Adolescent, and Young Adult Patients
1个月前
已完结
皖公网安备34019202002308
